Macitentan for PAH Endothelin receptor antagonist –Sustained receptor binding and enhanced tissue penetration Indication – functional class II, III, a
{"Image DocumentName": "Macitentan for PAH Endothelin receptor antagonist", "Image ImageDescription": "Sustained receptor binding and enhanced tissue penetration. Indication \u2013 functional class II, III, and IV. Administration \u2013 oral. Dosage = 10 mg daily. Macitentan is an endothelin receptor antagonist that has recently been approved for use in patients with PAH. It is indicated for patients in functional class II, III, and IV. The dosage of macitentan is 10 mg oral daily. 38.", "Image XResolution": "37", "Image YResolution": "37", "Image ResolutionUnit": "Pixels/Centimeter", "Image Software": "SlidePlayer", "Image YCbCrPositioning": "Centered"}